• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术后和非手术后新发免疫介导性血栓性血小板减少性紫癜:系统评价。

De-novo immune-mediated thrombotic thrombocytopenic purpura following surgical and non-surgical procedures: A systematic review.

机构信息

Department of Medicine, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.

Department of Medicine, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.

出版信息

Blood Rev. 2024 Jul;66:101197. doi: 10.1016/j.blre.2024.101197. Epub 2024 Apr 9.

DOI:10.1016/j.blre.2024.101197
PMID:38614840
Abstract

When de-novo immune-mediated thrombotic thrombocytopenic purpura (TTP) is diagnosed following an invasive procedure, clinical presentation patterns and outcomes are poorly defined. Therefore, in a systematic literature review of patients diagnosed with TTP following an invasive surgical or non-surgical procedure, we identified 19 studies reporting data on 25 patients. These data suggest that 1) TTP pathogenesis likely begins prior to the invasive procedure, 2) patients experience significant diagnostic delays, and 3) there is a high incidence of renal replacement therapy. Although invasive procedures may trigger TTP, further studies are needed to clarify the mechanisms underlying this association.

摘要

当侵袭性操作后新发免疫介导性血栓性血小板减少性紫癜(TTP)被诊断时,其临床表现模式和结局尚未明确。因此,我们对诊断为侵袭性手术或非手术操作后 TTP 的患者进行了系统文献回顾,共纳入 19 项研究,报道了 25 例患者的数据。这些数据提示:1)TTP 的发病机制可能在侵袭性操作之前开始;2)患者存在显著的诊断延迟;3)肾脏替代治疗的发生率较高。虽然侵袭性操作可能引发 TTP,但仍需要进一步研究以阐明其发病机制。

相似文献

1
De-novo immune-mediated thrombotic thrombocytopenic purpura following surgical and non-surgical procedures: A systematic review.手术后和非手术后新发免疫介导性血栓性血小板减少性紫癜:系统评价。
Blood Rev. 2024 Jul;66:101197. doi: 10.1016/j.blre.2024.101197. Epub 2024 Apr 9.
2
Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases.被误诊为血栓性血小板减少性紫癜的播散性恶性肿瘤:10例报告及已发表病例的系统评价
Oncologist. 2007 Jan;12(1):11-9. doi: 10.1634/theoncologist.12-1-11.
3
Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature.利妥昔单抗治疗与免疫介导的严重ADAMTS13缺乏相关的难治性和/或复发性血栓性血小板减少性紫癜:4例报告及文献系统综述
Eur J Haematol. 2009 Oct;83(4):365-72. doi: 10.1111/j.1600-0609.2009.01292.x. Epub 2009 Jun 8.
4
Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP): a consensus statement from the TTP Catalan group.血栓性血小板减少性紫癜(TTP)的诊断和临床管理:TTP 加泰罗尼亚小组的共识声明。
Blood Transfus. 2024 Mar;22(2):176-184. doi: 10.2450/BloodTransfus.522. Epub 2023 Sep 4.
5
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中,在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值:对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
6
Thrombotic thrombocytopenic purpura: Description and analysis of 23 cases treated in Chile between 2017 and 2022.血栓性血小板减少性紫癜:2017年至2022年在智利治疗的23例病例描述与分析
Medwave. 2025 Jul 21;25(6):e3002. doi: 10.5867/medwave.2025.06.3002.
7
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.接种 COVID-19 疫苗后的血栓性血小板减少性紫癜(TTP):已报告病例的系统评价。
Thromb Res. 2022 Jun;214:115-121. doi: 10.1016/j.thromres.2022.04.020. Epub 2022 May 2.
8
Immune Thrombotic Thrombocytopenic Purpura: A Review.免疫性血栓性血小板减少性紫癜:综述
JAMA. 2025 Aug 12;334(6):517-529. doi: 10.1001/jama.2025.3807.
9
HIV-associated thrombotic thrombocytopenic purpura (HIV-TTP): A practical guide and review of the literature.HIV 相关性血栓性血小板减少性紫癜(HIV-TTP):实用指南及文献复习。
HIV Med. 2022 Nov;23(10):1033-1040. doi: 10.1111/hiv.13305. Epub 2022 Apr 3.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

引用本文的文献

1
Managing surgical relapse risk in acquired thrombotic thrombocytopenic purpura: a systematic review.获得性血栓性血小板减少性紫癜手术复发风险的管理:一项系统评价
Res Pract Thromb Haemost. 2024 Jun 19;8(5):102478. doi: 10.1016/j.rpth.2024.102478. eCollection 2024 Jul.